$123.44
+0.02 (+0.02%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+18.58%
1Y
+60.56%
YTD
+22.41%
Open$123.49
Previous Close$123.42
Day High$123.52
Day Low$123.41
52W High$123.62
52W Low$71.13
Volume—
Avg Volume8.84M
Market Cap9.75B
P/E Ratio—
EPS$-6.05
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$103.76
Above
SMA 200
$88.57
Above
RSI (14)
53.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
24 analysts
Price Target
-73.0% upside
Current
$123.44
$123.44
Target
$33.28
$33.28
$20.12
$33.28 avg
$44.46
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.56B | 1.45B | 1.21B |
| Net Income | -302,764,100 | -377,638,036 | -264,320,064 |
| Profit Margin | -19.4% | -26.0% | -21.8% |
| EBITDA | -533,448,597 | -500,050,490 | -459,692,337 |
| Free Cash Flow | -391,442,676 | -279,670,611 | -274,115,194 |
| Rev Growth | +10.6% | +5.5% | +20.0% |
| Debt/Equity | 0.68 | 0.65 | 0.58 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.93 | +0.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.99 | +1.72% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.88 | +0.66% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $478.81 | +2.22% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $626.31 | +1.34% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $300.33 | +4.22% | 64.3 | 37.13B |